0001727073-24-000001.txt : 20240531 0001727073-24-000001.hdr.sgml : 20240531 20240531111816 ACCESSION NUMBER: 0001727073-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240531 DATE AS OF CHANGE: 20240531 EFFECTIVENESS DATE: 20240531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cage Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001727073 ORGANIZATION NAME: IRS NUMBER: 823580434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-514783 FILM NUMBER: 241008316 BUSINESS ADDRESS: STREET 1: 500 E. PRATT STREET STREET 2: SUITE 1200 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 917-733-1542 MAIL ADDRESS: STREET 1: 500 E. PRATT STREET STREET 2: SUITE 1200 CITY: BALTIMORE STATE: MD ZIP: 21202 D 1 primary_doc.xml X0708 D LIVE 0001727073 Cage Pharmaceuticals, Inc. 512 W. 22nd Street 5th Floor New York NY NEW YORK 10011 917-832-1832 DELAWARE None None Corporation true Peter Olagunju 512 W. 22nd Street 5th Floor New York NY NEW YORK 10011 Executive Officer Director Isaac Ro 512 W. 22nd Street 5th Floor New York NY NEW YORK 10011 Director Brian Malik 512 W. 22nd Street 5th Floor New York NY NEW YORK 10011 Director Nick Papadopoulos 512 W. 22nd Street 5th Floor New York NY NEW YORK 10011 Director Other Health Care Decline to Disclose 06b false 2024-05-01 false true false 0 137490 137490 0 false 2 0 0 0 false Cage Pharmaceuticals, Inc. /s/ Peter Olagunju Peter Olagunju Chief Executive Officer 2024-05-31